ATRC AtriCure, Inc.
AtriCure, Inc. (ATRC) is expected to report earnings on February 2, 2027, after the market close. The consensus earnings estimate is $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.7% since its last earnings release on November 3, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About AtriCure, Inc.
AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue.
Sector
Healthcare
Industry
Medical Instruments/Supply
Held By 2 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.